Faruqi Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages…Read More
You might also be interested in reading 1ST Biotherapeutics Joins The Michael J. Fox Foundation’s LITE Program to Advance LRRK2-Based Parkinson’s Disease Research.